Mangoceuticals, Inc.
StreetZero Signal 67
About Mangoceuticals, Inc.
Mangoceuticals, Inc. is a Texas-based public company operating in retail health and personal care products with a B2C business model focused on telehealth men's wellness. The company has secured additional equity funding through sales of Series B Convertible Preferred Stock and warrants as detailed in SEC filings. It maintains a website at www.mangoceuticals.com and has a LinkedIn presence with approximately 793 followers.
LATEST FUNDINGReg A
$10.0M
Announced 2026-11-12
IN THE NEWS
EMPLOYEES—
FOUNDED—
HQDallas, TX, United States
Industry
Other
Tags
TelehealthMen's WellnessPublic CompanyHealth Products
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $10M Reg A financing per funding records.
- Issued Series B Convertible Preferred Stock and warrants via amended securities purchase agreement.
- Secured $2.5M strategic investment in MangoRx IP Holdings with $1.75M initial tranche received.
- Public company pursuing commercialization of IP portfolio and product launches while managing dilution.
- Operates in retail health and personal care with B2C model and detected use of tools like Notion and Canva.
Tech stack
notioncanvaimpactlinkedinsnapchathootsuite
Ask StreetZero about Mangoceuticals, Inc.
Put our AI to work on this deal.
Similar companies
Other Other deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account